CD0271 0.1%/CD1579 2.5% gel
Drugone application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months
NCT Number: NCT01688531
Exploratory, international, multi-centre, randomized, investigator blinded study in acne
Looking for future studies?
Notify Me18 year–35 year
All sexes
Interventional
Phase 1
Galderma Investigational site, Windsor, Ontario, Canada
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months
one application (pea-sized amount according to the labelling) on a half-face, 5 to 7 days for 6 months
Time frame: over 6 months
Time frame: over 6 months
Galderma R&D
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07572331
Acne, Acne Vulgaris
Beverly, Massachusetts, United States
View Trial DetailsNCT07076784
Acne, Acne Scars
Seoul, South Korea
View Trial DetailsNCT07428954
Acne, Acne Vulgaris
Bilbao, Basque Country, Spain
View Trial DetailsNCT07428915
Acne, Acne Conglobata
Bilbao, Basque Country, Spain
View Trial Details